| Breakdown | TTM | Aug 2025 | Aug 2024 | Aug 2023 | Aug 2022 | Aug 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.55B | 7.28B | 6.58B | 5.62B | 4.76B | 3.68B |
| Gross Profit | 2.91B | 3.88B | 3.64B | 3.16B | 2.75B | 2.18B |
| EBITDA | 1.28B | 2.37B | 1.84B | 2.87B | 2.42B | 2.09B |
| Net Income | 388.40M | 966.38M | 418.00M | 1.38B | 1.84B | 1.44B |
Balance Sheet | ||||||
| Total Assets | 38.73B | 39.35B | 38.82B | 35.75B | 33.58B | 26.75B |
| Cash, Cash Equivalents and Short-Term Investments | 5.10B | 6.70B | 6.53B | 5.75B | 5.30B | 4.95B |
| Total Debt | 10.38B | 10.35B | 10.37B | 8.68B | 8.98B | 8.44B |
| Total Liabilities | 18.88B | 20.40B | 20.29B | 17.45B | 17.00B | 14.99B |
| Stockholders Equity | 17.54B | 16.74B | 15.85B | 15.57B | 14.01B | 10.92B |
Cash Flow | ||||||
| Free Cash Flow | 12.41M | 408.56M | 81.00M | 1.03B | 582.00M | -434.09M |
| Operating Cash Flow | 2.92B | 3.33B | 4.51B | 3.85B | 2.75B | 2.53B |
| Investing Cash Flow | -3.34B | -3.60B | -4.18B | -2.70B | -1.74B | -4.95B |
| Financing Cash Flow | 241.42M | -164.22M | 729.00M | -764.00M | 459.00M | 2.36B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$3.52B | 18.56 | 15.20% | ― | 7.50% | 5.93% | |
73 Outperform | HK$59.45B | 17.15 | 10.79% | 1.07% | 12.18% | 11.28% | |
72 Outperform | HK$2.44B | 7.15 | 37.38% | 5.86% | 72.87% | 54.16% | |
68 Neutral | HK$8.70B | 10.46 | 12.59% | 3.15% | 12.22% | 45.94% | |
64 Neutral | HK$5.21B | 5.82 | 4.58% | 9.49% | 8.65% | 142.58% | |
64 Neutral | HK$1.55B | 1.80 | 8.83% | ― | 0.06% | 12.04% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |